Gross Profit - Deciphera Pharmaceuticals Inc (F:D05) - Alpha Spread
D

Deciphera Pharmaceuticals Inc
F:D05

Watchlist Manager
Deciphera Pharmaceuticals Inc
F:D05
Watchlist
Price: 38.5 EUR 1.32% Market Closed
Market Cap: 3.2B EUR
Have any thoughts about
Deciphera Pharmaceuticals Inc?
Write Note

Deciphera Pharmaceuticals Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Deciphera Pharmaceuticals Inc
Gross Profit Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
D
Deciphera Pharmaceuticals Inc
F:D05
Gross Profit
$169.6m
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Gross Profit
$36.7B
CAGR 3-Years
1%
CAGR 5-Years
8%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Gross Profit
$21.5B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
4%
Amgen Inc
NASDAQ:AMGN
Gross Profit
$19.6B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Gross Profit
$8.9B
CAGR 3-Years
15%
CAGR 5-Years
24%
CAGR 10-Years
28%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Gross Profit
$11.7B
CAGR 3-Years
3%
CAGR 5-Years
14%
CAGR 10-Years
18%

See Also

What is Deciphera Pharmaceuticals Inc's Gross Profit?
Gross Profit
169.6m USD

Based on the financial report for Mar 31, 2024, Deciphera Pharmaceuticals Inc's Gross Profit amounts to 169.6m USD.

What is Deciphera Pharmaceuticals Inc's Gross Profit growth rate?
Gross Profit CAGR 3Y
36%

Over the last year, the Gross Profit growth was 31%. The average annual Gross Profit growth rates for Deciphera Pharmaceuticals Inc have been 36% over the past three years .

Back to Top